{
    "clinical_study": {
        "@rank": "124231", 
        "arm_group": [
            {
                "arm_group_label": "Chronic & Acute infected wounds", 
                "arm_group_type": "Experimental", 
                "description": "Wound will be cleaned with normal saline or tap water and Granulated sugar will be applied directly to the wound and covered with an absorbent pad and held in place with a bandage and tape."
            }, 
            {
                "arm_group_label": "Chronic and Acute infected wounds", 
                "arm_group_type": "Active Comparator", 
                "description": "Wound will be cleaned with normal saline or tap water and  an appropriate  debridement dressing (Aquacel or Sorbsan) is applied to the wound and secured with  a bandage and surgical tape."
            }
        ], 
        "brief_summary": {
            "textblock": "How effective is sugar in reducing the debriding of sloughy, necrotic or infected exudating\n      wounds compared with standard treatment?"
        }, 
        "brief_title": "Use of White Granulated Sugar on Wounds", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Infected Wounds", 
        "condition_browse": {
            "mesh_term": "Wound Infection"
        }, 
        "detailed_description": {
            "textblock": "Patients for whom all the following apply:\n\n      Have an exudating wound sizes 5cm2 and 40cm2 A minimum of 25% slough, infected and necrotic\n      tissue No dry necrotic eschar present Ankle Brachial Pressure Index of greater than 0.6 Are\n      over 18 years Independently and willingly consent"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Exudating wound sizes 5cm2 and 40cm2\n\n          -  A minimum of 25% slough, infected and necrotic tissue\n\n          -  No dry necrotic eschar\n\n          -  Ankle Brachial Pressure Index of greater than 0.6\n\n          -  Age over 18 years\n\n          -  Able to independently and willingly consent\n\n        Exclusion Criteria:\n\n          -  Participants in a trial evaluating other therapies for their wound\n\n          -  Have previously been in this trial\n\n          -  Women who are pregnant\n\n          -  Participants not able to tolerate daily dressing change"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "108", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01716273", 
            "org_study_id": "RRK4106"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Chronic & Acute infected wounds", 
                    "Chronic and Acute infected wounds"
                ], 
                "description": "30 grams of granulated sugar is used to cover the wound area  and this is held in place using a dry dressing pad , bandage and tape.", 
                "intervention_name": "Granulated Sugar", 
                "intervention_type": "Other", 
                "other_name": "Sucrose"
            }, 
            {
                "arm_group_label": [
                    "Chronic & Acute infected wounds", 
                    "Chronic and Acute infected wounds"
                ], 
                "description": "1 Aquacel or Sorbsan dressing will be put over the wound, and held in place with a dry dressing pad, bandage and tape.", 
                "intervention_name": "Debridement Dressing", 
                "intervention_type": "Other", 
                "other_name": "Aquacel or Sorbsan"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 26, 2012", 
        "location": {
            "contact": {
                "email": "rachel.hornabrook@uhb.nhs.uk", 
                "last_name": "Rachel Hornabrook", 
                "phone": "0121 697 8311"
            }, 
            "contact_backup": {
                "email": "carol.dealey@uhb.nhs.uk", 
                "last_name": "Carol Dealey, PhD", 
                "phone": "0121 697 8311"
            }, 
            "facility": {
                "address": {
                    "city": "Birmingham", 
                    "country": "United Kingdom", 
                    "state": "West Midlands", 
                    "zip": "B15 2TH"
                }, 
                "name": "University Hospital Birmingham NHS Foundation Trust"
            }, 
            "investigator": {
                "last_name": "Moses Murandu, PhD student", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomised Controlled Trial to Investigate the Clinical and Cost-effectiveness of White Granulated Sugar Dressing Compared With Standard Treatment in the Management of Exudating Wounds With Parallel Economic Evaluation", 
        "other_outcome": {
            "description": "Participants will be given a QOL questionnaire to complete before commencing the treatment and at the end of the 4 weeks", 
            "measure": "Quality of life", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "overall_contact": {
            "email": "mosesmurandu@wlv.ac.uk", 
            "last_name": "Moses Murandu, PhD student", 
            "phone": "07743025072"
        }, 
        "overall_contact_backup": {
            "email": "malcolm.simms@uhb.nhs.uk", 
            "last_name": "Malcolm Simms, MBBSFRCS", 
            "phone": "07768147025"
        }, 
        "overall_official": [
            {
                "affiliation": "University Hospital Birmingham NHS Fondation Trust", 
                "last_name": "Malcolm Simms, MBBSFRCS", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University of Wolverhampton", 
                "last_name": "Moses Murandu, PhD student", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United Kingdom: National Health Service", 
                "United Kingdom: Research Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "wounds will be photographed at entry into the study there after weekly till end of study at 4 weeks", 
            "measure": "Time to debridement of wound", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "reference": {
            "PMID": "21647066", 
            "citation": "Murandu M, Webber MA, Simms MH, Dealey C. Use of granulated sugar therapy in the management of sloughy or necrotic wounds: a pilot study. J Wound Care. 2011 May;20(5):206, 208, 210 passim."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01716273"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Birmingham", 
            "investigator_full_name": "Moses Murandu", 
            "investigator_title": "PhD student", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Wound measurements will be taken at entry into the study then weekly until end of 4 weeks", 
            "measure": "Reduction in wound surface area", 
            "safety_issue": "No", 
            "time_frame": "4 weeks"
        }, 
        "source": "University Hospital Birmingham", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Laboratoires URGO", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "University of Wolverhampton", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University of Birmingham", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Moses Murandu", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2012"
    }
}